Drug intelligence / Profile preview

PalinGen

Development stage
Unknown
Lead developer
Amnio Technology
Modality
Cell Therapies
Administration
Topical
01

Overview

PalinGen is a chorion-free human amniotic membrane allograft developed by Amnio Technology. It is processed from healthy amniotic tissue using the proprietary Advantek process, which excludes the chorion layer to minimize the potential for graft-versus-host autoimmune responses. PalinGen functions as a biological wound covering and physical barrier that provides structural support for native tissues, mimicking the protective role of the amniotic membrane during pregnancy. The allograft contains naturally occurring collagen substrates, growth factors, extracellular matrix proteins, cytokines, and regulatory proteins that facilitate the complex biological processes involved in wound healing. It is indicated for the treatment of full and partial-thickness, acute, and chronic wounds, as well as complex surgical wounds and burns.

Brand names
PalinGenPalinGen Membrane
Other names
PalinGen Membranechorion-free human amniotic membrane allograft

Beyond the preview

Go deeper on PalinGen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PalinGen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call